Osama Mohamed El-Wakeel

• Increased sales volume from the first month and achieved target volume from second month of hiring
• Developed and implemented sales strategies that resulted in significant growth
• Build strong relationship with KOLs in a short period of time
• Successful expanded the network of customers
• Organized scientific activities and group meetings to maintain customer relationships
• The previous tactics leaded to achieve over 100% from target volume for October and November
• October achievement is 106% and November achievement 114%
• Assigned to cover remote areas for western region from December 2024 and January 2025
• Creta doctor list by prospecting the remote areas
• Assigned territories for remote areas was Al Laith, Al Muzeluf, Al Qunfudah, Al Koz, Hali, Al Mikhwah and Adham
• I conducted a thorough analysis of the reasons behind the poor sales performance in the area, identifying the key issues
• Started to solve old situations with key accounts in governmental hospitals to push sales as soon as possible
• I succeeded in solving old issues within the first 2 weeks and new cases started to flow from governmental hospitals
• I developed strong relationships with doctors in poly clinics
• With follow up and persistence, sales volume increased from 280,000 SR to 420,000 SR for December and increased to 530,000 SR for January

• Best achiever for Behira region 2022
• Achievement for 2023 is 112%
• Achieve significant growth of total sales amount between 2020 and 2021 as 99% for 2020 and 123% for 2021
• Despite the difficulties encountered in launching new CNS molecule the new combination Olanzapine Fluoxetine (Psychlanz) achieved over than 150% from target in 2018
• Achieve continuous and maintain growth over 6 years of hard working
• Take the responsibility of launching Venllamash Venlafaxine molecule indicated as antidepressant molecule August 2017
• Best achiever of Venllamash new product allover Egypt starting from the 2nd month of launching
• Total achievement 2018 is 93%, 2019 94% total achievement, 2020 99% total achievement and 2021 is 123%
• Built new concepts and indications for positioning of Mirtimash Mirtazapine antidepressant which led to an increase in sales rates to an extent never reached before
• Promoted as a Senior product specialist for Behira region Jan 2019
• Best achiever for Behira Region 2018 and 2019

Responsibility has been assigned to promoting Hepatitis C drugs to help millions of people rid themselves of their suffering

• Launched the new combination Heterosofir Plus (Sofolanork+Dakalanork) as new drug for treating Hepatitis C patients they didn't responded to other drug.
• Assigned to take sales responsibility of launching Rupatadine antihistamine new molecule in the Egyptian market
• Best achiever in the newly launched molecule Rupatadine all over Egypt
• Penetrated new territories, successfully establishing relationships with 15 accounts.
• Achievement for Hepatitis C Newly Launched product was 89% after the first quarter and 134% for the first semester.
• Achievement for the newly launched antihistaminic molecule was 155% from the second month of launching and total achievement was 260%.

• Assigned to take sales responsibility of launching Eslicarbazebine anti convulsion new molecule in the Egyptian market
• Assigned to promote NET LOOK Isotretinoin Dermal product indicated in severe cases of acne
• Achieve 123% of NET LOOK target at the 2nd semester of 2015
• Promote CNS market leader product Tiratam as levetiracetam anti convulsion molecule